These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28964324)

  • 21. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
    Chang Y; Ryu S; Sung KC; Cho YK; Sung E; Kim HN; Jung HS; Yun KE; Ahn J; Shin H; Wild SH; Byrne CD
    Gut; 2019 Sep; 68(9):1667-1675. PubMed ID: 30472683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis).
    Desai CS; Ning H; Kang J; Folsom AR; Polak JF; Sibley CT; Tracy R; Lloyd-Jones DM
    Am J Cardiol; 2013 Jun; 111(11):1541-6. PubMed ID: 23499272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk factors in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
    Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.
    Mellinger JL; Pencina KM; Massaro JM; Hoffmann U; Seshadri S; Fox CS; O'Donnell CJ; Speliotes EK
    J Hepatol; 2015 Aug; 63(2):470-6. PubMed ID: 25776891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating oleic acid levels are related to greater risks of cardiovascular events and all-cause mortality: The Multi-Ethnic Study of Atherosclerosis.
    Steffen BT; Duprez D; Szklo M; Guan W; Tsai MY
    J Clin Lipidol; 2018; 12(6):1404-1412. PubMed ID: 30201531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
    Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
    JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.
    Wu S; Wu F; Ding Y; Hou J; Bi J; Zhang Z
    Sci Rep; 2016 Sep; 6():33386. PubMed ID: 27633274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Folsom AR; Kronmal RA; Detrano RC; O'Leary DH; Bild DE; Bluemke DA; Budoff MJ; Liu K; Shea S; Szklo M; Tracy RP; Watson KE; Burke GL
    Arch Intern Med; 2008 Jun; 168(12):1333-9. PubMed ID: 18574091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
    Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly.
    Jacobs K; Brouha S; Bettencourt R; Barrett-Connor E; Sirlin C; Loomba R
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1337-1344.e3. PubMed ID: 26820400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease.
    Elsaid MI; Li Y; Bridges JFP; Brock G; Minacapelli CD; Rustgi VK
    JAMA Netw Open; 2022 Oct; 5(10):e2235003. PubMed ID: 36205997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
    Jenny NS; Blumenthal RS; Kronmal RA; Rotter JI; Siscovick DS; Psaty BM
    J Thromb Haemost; 2014 Jun; 12(6):999-1005. PubMed ID: 24628740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults.
    Masrouri S; Shapiro MD; Khalili D; Hadaegh F
    Eur J Prev Cardiol; 2024 Apr; 31(6):744-753. PubMed ID: 38323650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
    Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
    J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
    Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
    Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population: Multi-Ethnic Study of Atherosclerosis.
    Goldwater D; Karlamangla A; Merkin SS; Watson K; Seeman T
    Ann Epidemiol; 2019 Feb; 30():9-14.e1. PubMed ID: 30249450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
    Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
    Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis.
    Wong MYZ; Yap JJL; Sultana R; Cheah M; Goh GBB; Yeo KK
    Open Heart; 2021 Dec; 8(2):. PubMed ID: 34933963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.